Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
J. Steven Lamberti, MD
PCC
Original Research
GLP-1 Analogs in Patients on Antipsychotics
February 6, 2020
Certain antipsychotics are known to increase weight and the risk for diabetes. Could some medications for diabetes promote not only glycemic control but also weight loss in patients taking...
Lauren T. Perlis
,
J. Steven Lamberti
,
Susanne U. Miedlich
JCP
Original Research
Changes in Metabolic Parameters With Switching to Aripiprazole From Another Second-Generation Antipsychotic: A Retrospective Chart Review
March 15, 2007
Ronald D. Spurling
,
J. Steven Lamberti
,
David Olsen
, et al
JCP
Original Research
Diabetes Mellitus Among Outpatients Receiving Clozapine: Prevalence and Clinical-Demographic Correlates
July 15, 2005
J. Steven Lamberti
,
G. Oana Costea
,
David Olson
, et al
JCP
Original Research
Prevalence of Diabetes Mellitus Among Outpatients With Severe Mental Disorders Receiving Atypical Antipsychotic Drugs
May 1, 2004
J. Steven Lamberti
,
John F. Crilly
,
Kumar Maharaj
, et al
JCP
Letter to the Editor
Priapism Associated With Polypharmacy
February 2, 2001
Anca Seger
,
J. Steven Lamberti
JCP
Letter to the Editor
Is Antipsychotic Drug-Induced Weight Gain Associated With a Favorable Clinical Response?
September 30, 2000
J. Steven Lamberti
